Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.

Fernandez-Sainz I, Gavitt TD, Koster M, Ramirez-Medina E, Rodriguez YY, Wu P, Silbart LK, de Los Santos T, Szczepanek SM.

Vaccine. 2019 Jun 6;37(26):3435-3442. doi: 10.1016/j.vaccine.2019.05.019. Epub 2019 May 10.

PMID:
31085001
2.

Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model.

Crossley RA, Matz A, Dew T, Kalinauskas A, Faucette N, Poff B, Silbart LK, Suckow MA.

Anticancer Res. 2019 Apr;39(4):1699-1703. doi: 10.21873/anticanres.13275.

PMID:
30952708
3.

Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.

Beaudet J, Tulman ER, Pflaum K, Canter JA, Silbart LK, Geary SJ.

Infect Immun. 2019 Feb 21;87(3). pii: e00613-18. doi: 10.1128/IAI.00613-18. Print 2019 Mar.

4.

Transcriptional Profiling of the Chicken Tracheal Response to Virulent Mycoplasma gallisepticum Strain Rlow.

Beaudet J, Tulman ER, Pflaum K, Liao X, Kutish GF, Szczepanek SM, Silbart LK, Geary SJ.

Infect Immun. 2017 Sep 20;85(10). pii: e00343-17. doi: 10.1128/IAI.00343-17. Print 2017 Oct.

5.

Interaction of Mycoplasma gallisepticum with Chicken Tracheal Epithelial Cells Contributes to Macrophage Chemotaxis and Activation.

Majumder S, Silbart LK.

Infect Immun. 2015 Nov 2;84(1):266-74. doi: 10.1128/IAI.01113-15. Print 2016 Jan.

6.
7.

Bromelain Inhibits Allergic Sensitization and Murine Asthma via Modulation of Dendritic Cells.

Secor ER Jr, Szczepanek SM, Castater CA, Adami AJ, Matson AP, Rafti ET, Guernsey L, Natarajan P, McNamara JT, Schramm CM, Thrall RS, Silbart LK.

Evid Based Complement Alternat Med. 2013;2013:702196. doi: 10.1155/2013/702196. Epub 2013 Dec 5.

8.

Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma.

Siddiqui S, Secor ER Jr, Silbart LK.

Cell Immunol. 2013 Feb;281(2):159-69. doi: 10.1016/j.cellimm.2013.03.001. Epub 2013 Mar 27.

PMID:
23685352
9.

Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F(ab).

Wanczyk H, Barker T, Rood D, Zapata DI, Howell AR, Richardson SK, Zinckgraf J, Marusov GP, Lynes MA, Silbart LK.

Toxins (Basel). 2013 Mar 19;5(3):568-89. doi: 10.3390/toxins5030568.

10.

An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.

Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.

Vaccine. 2013 Apr 26;31(18):2302-9. doi: 10.1016/j.vaccine.2013.02.060. Epub 2013 Mar 13.

PMID:
23499593
11.

LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr.

Secor ER Jr, Szczepanek SM, Singh A, Guernsey L, Natarajan P, Rezaul K, Han DK, Thrall RS, Silbart LK.

Evid Based Complement Alternat Med. 2012;2012:548486. doi: 10.1155/2012/548486. Epub 2012 Oct 2.

12.

Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Szczepanek SM, Barrette RW, Rood D, Alejo D, Silbart LK.

Clin Vaccine Immunol. 2012 Apr;19(4):461-7. doi: 10.1128/CVI.00035-12. Epub 2012 Feb 8.

13.

Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs.

Challa S, Szczepanek SM, Rood D, Barrette RW, Silbart LK.

Adv Virol. 2011;2011:713769. doi: 10.1155/2011/713769. Epub 2011 Sep 22.

14.

Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.

Szczepanek SM, Majumder S, Sheppard ES, Liao X, Rood D, Tulman ER, Wyand S, Krause DC, Silbart LK, Geary SJ.

Infect Immun. 2012 Mar;80(3):1007-14. doi: 10.1128/IAI.06078-11. Epub 2012 Jan 17.

15.

A microarray biosensor for multiplexed detection of microbes using grating-coupled surface plasmon resonance imaging.

Marusov G, Sweatt A, Pietrosimone K, Benson D, Geary SJ, Silbart LK, Challa S, Lagoy J, Lawrence DA, Lynes MA.

Environ Sci Technol. 2012 Jan 3;46(1):348-59. doi: 10.1021/es201239f. Epub 2011 Dec 1.

16.

Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine.

Barrette RW, Szczepanek SM, Rood D, Challa S, Avery N, Vajdy M, Kramer E, Rodriguez L, Silbart LK.

Clin Vaccine Immunol. 2011 Nov;18(11):1996-8. doi: 10.1128/CVI.05273-11. Epub 2011 Sep 14.

17.

Outer membrane protein A (OmpA) of Cronobacter sakazakii binds fibronectin and contributes to invasion of human brain microvascular endothelial cells.

Nair MK, Venkitanarayanan K, Silbart LK, Kim KS.

Foodborne Pathog Dis. 2009 May;6(4):495-501. doi: 10.1089/fpd.2008.0228.

PMID:
19415974
18.

Dual fluorescent labeling method to visualize plasmid DNA degradation.

Srinivasan C, Siddiqui S, Silbart LK, Papadimitrakopoulos F, Burgess DJ.

Bioconjug Chem. 2009 Jan;20(1):163-9. doi: 10.1021/bc800184j.

PMID:
19086903
19.

Pulmonary eosinophilia correlates with allergen deposition to the lower respiratory tract in a mouse model of asthma.

Siddiqui S, Morris J, Avery N, Wyand S, Rood D, Silbart LK.

Clin Exp Allergy. 2008 Aug;38(8):1381-90. doi: 10.1111/j.1365-2222.2008.03009.x. Epub 2008 Jun 4.

PMID:
18537985
20.

Comparative assessment of a metabolically attenuated Mycoplasma gallisepticum mutant as a live vaccine for the prevention of avian respiratory mycoplasmosis.

Gates AE, Frasca S, Nyaoke A, Gorton TS, Silbart LK, Geary SJ.

Vaccine. 2008 Apr 7;26(16):2010-9. doi: 10.1016/j.vaccine.2008.02.010. Epub 2008 Feb 22.

PMID:
18342996
21.

Chemokine and cytokine gene expression profiles in chickens inoculated with Mycoplasma gallisepticum strains Rlow or GT5.

Mohammed J, Frasca S Jr, Cecchini K, Rood D, Nyaoke AC, Geary SJ, Silbart LK.

Vaccine. 2007 Dec 12;25(51):8611-21. Epub 2007 Oct 16.

PMID:
18006123
22.
23.

Enhanced phosphorus nutrition in monocots and dicots over-expressing a phosphorus-responsive type I H+-pyrophosphatase.

Yang H, Knapp J, Koirala P, Rajagopal D, Peer WA, Silbart LK, Murphy A, Gaxiola RA.

Plant Biotechnol J. 2007 Nov;5(6):735-45. Epub 2007 Aug 16.

24.

Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus.

Challa S, Barrette R, Rood D, Zinckgraf J, French R, Silbart L.

Vaccine. 2007 Apr 30;25(17):3328-37. Epub 2007 Jan 12.

PMID:
17276557
25.

Quantifying specific antibody concentrations by enzyme-linked immunosorbent assay using slope correction.

Barrette RW, Urbonas J, Silbart LK.

Clin Vaccine Immunol. 2006 Jul;13(7):802-5.

26.

Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots.

Srinivasan C, Lee J, Papadimitrakopoulos F, Silbart LK, Zhao M, Burgess DJ.

Mol Ther. 2006 Aug;14(2):192-201. Epub 2006 May 12.

27.
28.
29.

Immune response to a mucosally administered aflatoxin B1 vaccine.

Wilkinson J, Rood D, Minior D, Guillard K, Darre M, Silbart LK.

Poult Sci. 2003 Oct;82(10):1565-72.

PMID:
14601734
30.
32.

A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease.

Papazisi L, Silbart LK, Frasca S, Rood D, Liao X, Gladd M, Javed MA, Geary SJ.

Vaccine. 2002 Nov 1;20(31-32):3709-19.

PMID:
12399199
33.

High affinity binding site-mediated prevention of chemical absorption across the gastrointestinal tract.

Rasmussen MV, Barker TT, Silbart LK.

Toxicol Lett. 2001 Dec 15;125(1-3):51-9.

PMID:
11701222
34.

Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide.

Zinckgraf JW, Winchell JM, Silbart LK.

J Reprod Immunol. 1999 Dec;45(2):99-112.

PMID:
10674979
35.

Peroral administration of specific antibody enhances carcinogen excretion.

Rasmussen MV, Silbart LK.

J Immunother. 1998 Nov;21(6):418-26.

PMID:
9807736
36.

Mucosal and systemic antibody responses to a C4/V3 construct following DNA vaccination of rabbits via the Peyer's patch.

Winchell JM, Routray S, Betts PW, Van Kruiningen HJ, Silbart LK.

J Infect Dis. 1998 Sep;178(3):850-3.

PMID:
9728557
37.

Local and systemic tolerance to orally administered dinitrochlorobenzene is not broken by cholera toxin.

Oliver AR, Silbart LK.

Int Arch Allergy Immunol. 1998 Aug;116(4):318-24.

PMID:
9693283
38.

Mucosal immune response to an HIV C4/V3 peptide following nasal or intestinal immunization of rabbits.

Winchell JM, Van Kruiningen HJ, Silbart LK.

AIDS Res Hum Retroviruses. 1997 Jul 1;13(10):881-9.

PMID:
9197382
39.

Mucosal unresponsiveness to aflatoxin B1 is not broken by cholera toxin.

Oliver AR, Silbart LK, Keren DF, Van Kruiningen HJ, Miller BF, Rearick C.

Immunol Cell Biol. 1997 Feb;75(1):47-53.

40.

Immunoprophylactic intervention in chemical toxicity and carcinogenicity.

Silbart LK, Rasmussen MV, Oliver AR.

Vet Hum Toxicol. 1997 Feb;39(1):37-43. Review.

PMID:
9004467
41.

A simplified procedure for studies of intestinal immunity in rabbits.

McAleer FT, Silbart LK, Van Kruiningen HJ, Koudelka J, Tobias A.

J Immunol Methods. 1996 Jul 17;194(1):49-58.

PMID:
8690940
42.

Selective induction of mucosal immune responses to 2-acetylaminofluorene.

Silbart LK, McAleer F, Rasmussen MV, Goslinoski L, Keren DF, Finley A, Van Kruiningen HJ, Winchell JM.

Anticancer Res. 1996 Mar-Apr;16(2):651-60.

PMID:
8687111
43.

Mucosal tolerance to aflatoxin B1.

Oliver AR, Silbart LK, Keren DF, Miller B, McDonald RA.

Ann N Y Acad Sci. 1996 Feb 13;778:422-4. No abstract available.

44.

Characterization of the mucosal immune response to 2-acetylaminofluorene-protein conjugates.

Silbart LK, Keren DF, McDonald RA, Lincoln PM, Goslinoski L, Smart JB.

Reg Immunol. 1992 Jul-Aug;4(4):245-54.

PMID:
1476877
45.

Human N-acetylation genotype determination with urinary caffeine metabolites.

Kilbane AJ, Silbart LK, Manis M, Beitins IZ, Weber WW.

Clin Pharmacol Ther. 1990 Apr;47(4):470-7. Erratum in: Clin Pharmacol Ther 1992 Oct;52(4):349.

46.

Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity.

Silbart LK, Keren DF.

Science. 1989 Mar 17;243(4897):1462-4.

PMID:
2928780
47.

A rapid and sensitive screening method for the detection of anti-2-acetylaminofluorene immunoglobulins.

Silbart LK, Nordblom G, Keren DF, Wise DS Jr, Lincoln PM, Townsend LB.

J Immunol Methods. 1988 Apr 22;109(1):103-12.

48.

Significance of immune responses to mucosal carcinogens: a hypothesis and a workable model system.

Keren DF, Silbart LK, Lincoln PM, Annesley TM.

Pathol Immunopathol Res. 1986;5(3-5):265-77.

PMID:
3601874

Supplemental Content

Loading ...
Support Center